MXT Share Price | nDatalyze Corp. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare nDatalyze Corp. with Similar Stocks

Ayurcann Holdings Corp.Lotus Ventures, Inc.Sweet Earth Holdings Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 4 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.41

Return on Equity

-30.44%

Price to Book

4.13

Revenue and Profits:

Net Sales:

(Quarterly Results - Nov 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

566.67%

6 Months

566.67%

1 Year

400.0%

2 Years

-28.57%

3 Years

-33.33%

4 Years

-57.45%

5 Years

-58.33%

nDatalyze Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-16.33%

EBIT Growth (5y)

-4.85%

EBIT to Interest (avg)

-0.80

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.52

Sales to Capital Employed (avg)

0.06

Tax Ratio

4.27%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.05%

ROE (avg)

0.15%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

4.13

EV to EBIT

-3.72

EV to EBITDA

-3.72

EV to Capital Employed

3.72

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-22.04%

ROE (Latest)

-30.44%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 0.00% vs 0.00% in Aug 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is 0.00% vs 0.00% in Aug 2025",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is -100.00% vs -50.00% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is -200.00% vs 83.33% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.60",
          "val2": "-0.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.60",
          "val2": "-0.20",
          "chgp": "-200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-372,204.80%",
          "val2": "-3,285.80%",
          "chgp": "-36,891.90%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ

Nov'25

Aug'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.10

-0.00

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.00

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Nov 2025 is 0.00% vs 0.00% in Aug 2025

Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is 0.00% vs 0.00% in Aug 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Feb'25

Feb'25

Feb'24

Change(%)

Net Sales

0.00

0.10

-100.00%

Operating Profit (PBDIT) excl Other Income

-0.60

-0.30

-100.00%

Interest

0.00

Exceptional Items

-0.10

-0.00

Consolidate Net Profit

-0.60

-0.20

-200.00%

Operating Profit Margin (Excl OI)

-372,204.80%

-3,285.80%

-36,891.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Feb 2025 is -100.00% vs -50.00% in Feb 2024

Consolidated Net Profit

YoY Growth in year ended Feb 2025 is -200.00% vs 83.33% in Feb 2024

All Annual Results

Company CV

About nDatalyze Corp.

nDatalyze Corp.

Pharmaceuticals & Biotechnology

MedXtractor Corp is a Canada-based company engaged in pharmaceutical sector. The Company is engaged in the business of manufacturing and selling a range of supercritical small scale carbon dioxide based extractors (CO2 Extractors) that are used to extract essential oils and compounds from a variety of botanical materials. The Corporation manufactures CO2 Extractors of 2ounce, 5ounce and 16ounce capacities.

Company Coordinates

Company Details

5614A Burbank Road SE , CALGARY AB : T2H 1Z4

Tel: 1 780 9960049

https://medxtractor.com/

Registrar Details